Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure
Author:
Funder
Boston Scientific Corporation
Abbott Laboratories
Biosense Webster
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials;Reddy;J Am Coll Cardiol,2017
2. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis;Holmes;J Am Coll Cardiol,2015
3. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial;Reddy;Circulation,2013
4. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial;Reddy;JAMA,2014
5. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised noninferiority trial;Holmes;Lancet,2009
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk factors, clinical implications, and management of peridevice leak following left atrial appendage closure: A systematic review;Journal of Interventional Cardiac Electrophysiology;2024-01-06
2. Stroke Prevention in Atrial Fibrillation: Our Current Failures and Required Research;Stroke;2024-01
3. Use of Computed Tomography for Left Atrial Appendage Occlusion Procedure Planning and Post-Procedure Assessment;Interventional Cardiology Clinics;2024-01
4. Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis;European Heart Journal;2023-12-13
5. Anticoagulants versus Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Co-Morbid Thrombocytopenia;Journal of Clinical Medicine;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3